| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |